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ABSTRACT	 	Migraines	are	severe,	recurring,	and	painful	headaches.	The	extreme	pain	have	that	migraines	cause	can	last	for	hours	or	even	days.	Migraines	can	follow	an	aura	of	sensory	disturbances	followed	by	a	severe	headache	that	often	appears	on	one	side	of	the	head.	Objective	of	the	study	include;	To	find	out	whether	male	and	female	are	more	prone	to	develop	migraine,	To	evaluate	which	triggering	factors	contributes	to	migraine	and	To	evaluate	the	people	taking	OTC	for	migraine.	A	Prospective	survey	will	be	carried	out	in	75	peoples	using	the	information’s	gathered	from	students	in	Pharmacy	colleges	in	Trivandrum.	This	study	provides	the	 prevalence	 of	 migraine	 headache.	 Past	 history,	 medication	 usage,	 diagnosis,	 treatment,	 triggering	factors,	physical	and	intellectual	activities	was	collected,	analysed	properly	and	response	is	recorded.	These	collected	data	will	be	subjected	to	statistical	analysis.	In	the	current	research,	a	survey	on	functioning	of	male	and	female	with	migraine	was	formulated.	Among	the	respondents	about	18-35	age	group	is	commonly	affected	migraine	with	98.7%	(n=74).	Approximately,	63.5%	(n=47)	female	are	affected	with	migraine	than	36.5%	(n=27)	male.	About	11.16%	(n=8)	of	patients	taken	prescription	drugs	and	52.2%	(n=48)	are	taken	over-the-counter	medicines.	Migraine	worsened	in	77.20%	(n=48)	patients	with	stress,	50%	(n=33)	bright	sunshine,	33.30%	(n=22)		loud	noise	and	others	have	air	travel,	fatigue,	certain	smells	and	perfume.	The	goal	of	management	is	to	reduce	frequency	and	severity	of	episodes	in	males	and	females.	Also	limit	the	impact	of	this	chronic	pain	condition.	
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INTRODUCTION	Migraine	 affects	 roughly	 12%	 of	 the	 adults	 in	occidental	countries[1,2].	In	US	population	studies,	the	prevalence	 of	 migraine	 is	 approximately	 18%	 in	
women	and	6%	in	men[3-5].	Approximately	90%	of	the	migraineurs	 have	 moderate	 or	 severe	 pain,	 three	quarters	have	a	reduced	ability	to	function	during	the	headache	 attacks,	 and	 one-third	 require	 bed	 rest	during	their	attacks.		Migraine	 is	 also	 undertreated	 in	 the	 United	 States,	though	 most	 studies	 have	 focused	 on	 acute	treatment[6-9].	 Most	 migraineurs	 treat	 their	headaches	with	acute	treatments	to	the	exclusion	of	preventive	 drugs[5,10,11].	 The	 US	 Headache	Consortium	Guidelines	discuss	indications	for	the	use	of	 preventive	 medication,	 but	 do	 not	 provide	operational	criteria[12].	Because	attack	frequency	and	medication	 overuse	 are	 risk	 factors	 for	 headache	progression,	it	is	possible	that	preventive	medication	may	also	reduce	the	risk	of	progression[12-15].	According	to	the	American	Migraine	Association,	they	affect	 36	 million	 Americans,	 or	 approximately	 12	percent	 of	 the	 population.	 Migraines	 can	 follow	 an	aura	 of	 sensory	 disturbances	 followed	 by	 a	 severe	headache	that	often	appears	on	one	side	of	the	head.	They	tend	to	affect	people	aged	18	to	55	years.	
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OBJECTIVE	This	study	is	to	conduct	a	survey	based	on	prevalence	of	migraine	headache	in	males	and	females	in	colleges	of	Thiruvananthapuram.	The	objective	of	 this	study	to	 assess	 the	 prevalence	 of	 migraine	 headache	 in	males	and	females;	1. To	 find	 out	 whether	 male	 and	 female	 are	more	prone	to	develop	migraine.	2. To	evaluate	the	triggering	factors	associated	with	migraine.	3. To	evaluate	the	pattern	of	OTC	for	migraine.	
METHODOLOGY	A	 Prospective	 survey	 was	 carried	 out	 using	 the	information’s	 gathered	 from	 students	 in	 Pharmacy	colleges	 in	 Trivandrum.	 This	 study	 provides	 the	prevalence	 of	 migraine	 headache	 in	 males	 and	females.	 Past	 history,	 medication	 usage,	 diagnosis,	treatment,	 triggering	 factors,	 physical	 and	intellectual	 activities	 was	 collected	 and	 analysed	properly.	Also	response	was	recorded.	The	duration	of	the	study	was	1	month,	in	October	2018.	A	web	based	questionnaire	was	developed	with	20	questions	and	employed	to	collect	data	from	students	at	different	colleges	 in	Thiruvananthapuram.	 It	was	prepared	 in	 Google	 form	 and	 distributed	 through	sending	 link	 to	 students	 through	 social	 media.	Inclusion	criteria	are	 the	Age	over	18-55	years	and	exclusion	 criteria	 are	 the	 Pregnancy,	 Lactation,	 age	below	18years	and	age	above	28	years	people.	
DATA	COLLECTION		Data	 collection	was	 done	with	 the	 self-filled	 online	forms.	Data	were	collected	during	the	month,	October	2018.	 Willing	 participants	 were	 only	 chosen	 for	study.	Questionnaires	were	filled	by	80	subjects.	75	responded	 to	 the	 questions.	 The	 study	 was	descriptive	and	data	was	summarized	as	counts	and	percentages.	
STATISTICAL	ANALYSIS	All	 data	 collected	 was	 statistically	 analysed	 and	performed.	 All	 statistical	 assessments	 were	 two-tailed	and	the	level	of	significance	was	set	at	p<0.05.	
RESULT	In	 the	 current	 research,	 a	 survey	 on	 functioning	 of	male	 and	 female	 with	 migraine	 was	 formulated.	Approximately,	 63.5%	 (n=47)	 female	 are	 affected	with	 migraine	 than	 36.5%	 (n=27)	 male.	 Migraine	headache	in	people	with	pain	is	categorized	as	19.4%	have	mild,	33.3%	have	moderate	and	severe.	About	21.3%	have	nausea,	30.7%	have	vomiting	and	42.7%	
bothered	 by	 light	 or	 noise	 before	 or	 during	 the	headache.		
 
Figure 1: Among 75 responders 63.5% (n=47) females 
and 36.5% (n=27) males affected with migraine.	
 
Figure 2: Among 75 responders 48%(n=36) peoples us-
ing OTC medicines and 52%(n=33) are not use.	
 
Figure 3: Among 75 responders 24.20% (n=16) certain 
smells or perfume, 25.80% (n=17)  missed meal, 
33.30% (n=22)  loud noise, 50%(n=33) bright sunshine 
and 77.20% (n=48)  stress are the triggering factors af-
fect migraine.	
 
Figure 4: Among 75 responders 62.70% (n=47) rest, 
25.30% (n=19) quite and darkness, 33.30% (n=25) 
massage, 18.70% (n=14) pressure over migraine head-
ache area and 13.30% (n=10) warm shower to treat 
migraine.	
DISCUSSION	In	 the	 current	 research,	 a	 survey	 on	 functioning	 of	male	 and	 female	 with	 migraine	 was	 formulated.	
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Among	 the	 respondents	 about	 18-35	 age	 group	 is	commonly	 affected	 migraine	 with	 98.7%	 (n=74).	Approximately,	 63.5%	 (n=47)	 female	 are	 affected	with	 migraine	 than	 36.5%	 (n=27)	 male.	 Migraine	headache	in	people	with	pain	is	categorized	as	19.4%	(n=14)	 have	 mild,	 33.3%	 (48)	 have	 modeate	 and	severe.	 About	 21.3%	 (n=16)	 have	 nausea,	 30.7%	(n=23)	have	vomiting	and	42.7%(n=32)	bothered	by	light	or	noise	before	or	during	 the	headache.	About	48.3%	 (n=14)	 peoples	 have	 mother	 affected	 with	migraine.	 Approximately,	 8.5%	 (n=6)	 people	requiring	medical	 treatment	 for	 neck/	 head	 injury.	About	 11.16%	 (n=8)	 of	 patients	 taken	 prescription	drugs	 include	 Metaphor,	 Sibilium	 and	 Flunarazine.	About	 52.2%	 (n=48)	 are	 taken	 over-the-counter	medicines.	 Commonly	 taking	 paracetamol	 as	 OTC	medicine.	 Migraine	 worsened	 in	 77.20%	 (n=48)	patients	 with	 stress,	 50%	 (n=33)	 bright	 sunshine,	33.30%	(n=22)		loud	noise	and	others	have	air	travel,	fatigue,	 certain	 smells	 and	 perfume.	 About	 48.5%	(n=33)	of	people	have	migraine	moderately	affect	the	quality	of	life.	
CONCLUSION	The	goal	of	management	is	to	reduce	frequency	and	severity	of	episodes	in	males	and	females.	Also	limit	the	impact	of	this	chronic	pain	condition.	It	can	help	to	identify	triggers,	gain	increased	understanding	of	what	 happens	 in	 the	 brain	 and	 body	 during	 the	migraine	and	get	clues	to	treatments	or	even	a	cure.	It	help	to	analyze	whether	these	students	practicing	stress	 management	 and	 relaxation	 technique	 to	reduce	migraine.	
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